Key Highlights
- 35% lower total care costs for CGM patients using medical benefits over pharmacy.
- 23% higher adherence to CGM therapy through medical benefit.
- CCS presented findings at ADCES and ISPOR conferences.
- AI-powered PropheSee™ model boosts patient adherence by up to 50%.
Source: Business Wire
Notable Quotes
- “CGMs are only effective if people use them. This first-of-its-kind research demonstrates that a physician’s decision to direct a patient to use their medical benefit instead of their pharmacy benefit when accessing a medical device can seriously impact health outcomes and costs of care.” — Dr. Arti Masturzo, Chief Medical Officer at CCS
- “They’ve coached me on how to use a CGM and helped educate me on the value of using my medical benefit.” — Scott Gerberich, Patient
SoHC's Take
The research from CCS underscores the importance of ensuring that patients access continuous glucose monitoring (CGM) devices through their medical benefits instead of pharmacy benefits. The data-driven insights highlight significant cost savings and improved adherence, which are crucial for both patient outcomes and healthcare sustainability. CCS’s integration of education, coaching, and AI-driven predictive tools further cements its role as a leader in chronic care management, particularly for diabetes care. With rising CGM adoption and an urgent need for effective patient support, CCS’s innovations, like PropheSee™, offer a promising model for the future of proactive chronic care management.
Heading
Key Highlights Ginkgo Bioworks releases first proprietary protein LLM, trained on exclusive datasets.Collaboration with Google Cloud enables AI-driven drug discovery tools.Open API allows researchers to access Ginkgo’s machine ...
Key Highlights Courtney Green joins QGenda as Vice President of Nurse and Staff Solutions.Brings over 20 years of clinical and operational leadership experience.Focus on optimizing ...
Key Highlights Vyne Medical® acquires Extract Systems®, a leader in data extraction solutions.Accelerates healthcare automation by integrating AI and machine learning ...
Key Highlights PatientPay integrates with Azalea Health’s API to streamline patient billing for ambulatory providers.Faster revenue capture with less than 14 days to payment, ...
Key Highlights Partnership streamlines revenue cycle management for ABA therapy providers.Flychain’s financial tools offer real-time insights, secure funding, and automation.Raven ...
Key Highlights Nura Bio closes $140M Series A financing to support clinical development.Shilpa Sambashivan, Ph.D., appointed as CEO following Phase 1 success ...
